Get the Stockscreener App
149.75
0.30%
-0.45
Pre-market:
150.50
0.75
+0.50%
Krystal Biotech Inc stock is traded at $149.75, with a volume of 222.59K.
It is down -0.30% in the last 24 hours and up +10.98% over the past month.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
See More
Previous Close:
$150.20
Open:
$149.33
24h Volume:
222.59K
Relative Volume:
0.63
Market Cap:
$4.33B
Revenue:
$290.51M
Net Income/Loss:
$89.16M
P/E Ratio:
50.08
EPS:
2.99
Net Cash Flow:
$119.18M
1W Performance:
-0.67%
1M Performance:
+10.98%
6M Performance:
-14.54%
1Y Performance:
-19.47%
1-Day Range:
$148.04
$150.39
1-Week Range:
$145.47
$152.56
52-Week Range:
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
Name
Krystal Biotech Inc
Sector
Industry
Phone
(412) 586-5830
Address
2100 WHARTON STREET, PITTSBURGH, PA
Compare KRYS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
149.75 | 4.31B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-25 | Initiated | Jefferies | Buy |
| Aug-06-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-20-23 | Initiated | Goldman | Buy |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-12-23 | Initiated | Citigroup | Buy |
| Sep-07-23 | Initiated | Berenberg | Buy |
| Apr-18-23 | Initiated | Stifel | Buy |
| Feb-28-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-25-22 | Downgrade | Goldman | Buy → Neutral |
| Jan-18-22 | Initiated | BofA Securities | Buy |
| Jul-20-21 | Upgrade | Goldman | Neutral → Buy |
| Sep-18-20 | Initiated | B. Riley FBR | Buy |
| Jun-04-20 | Initiated | Evercore ISI | Outperform |
| Sep-24-19 | Initiated | Goldman | Neutral |
| Aug-06-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-19 | Reiterated | Chardan Capital Markets | Buy |
| Jun-24-19 | Reiterated | H.C. Wainwright | Buy |
| May-30-19 | Initiated | Guggenheim | Buy |
| Sep-11-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Krystal Biotech Inc Stock (KRYS) Latest News
Using flow based indicators on Krystal Biotech Inc.Gold Moves & Fast Entry Momentum Trade Alerts - Newser
Published on: 2025-09-04 08:33:01 - Newser
Using data models to predict Krystal Biotech Inc. stock movementStop Loss & Accurate Entry/Exit Alerts - Newser
Will Krystal Biotech Inc. stock recover after recent dropBear Alert & Growth Focused Investment Plans - Newser
Best data tools to analyze Krystal Biotech Inc. stockTreasury Yields & Fast Entry Momentum Trade Alerts - Newser
What is the earnings history of Krystal Biotech Inc.Market Trend Report & AI Powered Buy/Sell Recommendations - khodrobank.com
Is Krystal Biotech Inc. a defensive stockJuly 2025 Highlights & AI Powered Buy and Sell Recommendations - khodrobank.com
Krystal Biotech (KRYS) Up 8.5% Since Last Earnings Report: Can It Continue? - ca.finance.yahoo.com
When is the best time to exit Krystal Biotech Inc.July 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser
High Growth Tech Stocks In US For September 2025 - Yahoo Finance
Applying big data sentiment scoring on Krystal Biotech IncForecast Cut & AI Forecast Swing Trade Picks - Newser
Will Krystal Biotech Inc. continue its uptrendMarket Activity Summary & Free Daily Entry Point Trade Alerts - Newser
What are Krystal Biotech Inc.’s recent SEC filings showingFed Meeting & Fast Entry and Exit Trade Plans - khodrobank.com
Analyzing recovery setups for Krystal Biotech Inc. investorsFed Meeting & Technical Confirmation Alerts - Newser
Understanding Krystal Biotech Inc.’s price movementJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
What recovery options are there for Krystal Biotech Inc.Weekly Market Outlook & Weekly Chart Analysis and Trade Guides - Newser
What candlestick patterns are forming on Krystal Biotech Inc.Trend Reversal & Capital Protection Trade Alerts - Newser
Ranking Krystal Biotech Inc. among high performing stocks via toolsRecession Risk & High Return Stock Watch Alerts - Newser
Is this a good reentry point in Krystal Biotech Inc.Weekly Market Outlook & Weekly Market Pulse Updates - Newser
Building trade automation scripts for Krystal Biotech Inc.Quarterly Portfolio Report & Real-Time Buy Zone Alerts - Newser
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025 - The Manila Times
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025: CEO to Participate in Fireside Chat and Host Investor Meetings - AInvest
Gene Therapy Leader Krystal Biotech to Present at Major Healthcare Conference in New York - Stock Titan
How to forecast Krystal Biotech Inc. trends using time seriesQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser
Regression analysis insights on Krystal Biotech Inc. performancePrice Action & Daily Oversold Stock Bounce Ideas - Newser
How to use Fibonacci retracement on Krystal Biotech Inc.Trade Entry Summary & Daily Entry Point Alerts - Newser
Key metrics from Krystal Biotech Inc.’s quarterly dataWeekly Profit Report & Smart Money Movement Tracker - Newser
Published on: 2025-09-02 02:18:02 - Newser
Is Krystal Biotech Inc. in a bullish channelQuarterly Investment Review & Safe Capital Allocation Plans - khodrobank.com
Will Krystal Biotech Inc. price bounce be sustainableJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
Using data filters to optimize entry into Krystal Biotech Inc.Bear Alert & Low Risk High Win Rate Stock Picks - Newser
Should I average down on Krystal Biotech Inc. stockJuly 2025 Macro Moves & Weekly Setup with ROI Potential - khodrobank.com
How do insiders feel about Krystal Biotech Inc.July 2025 Movers & Low Risk High Win Rate Stock Picks - khodrobank.com
Order flow analysis tools used on Krystal Biotech Inc.2025 Institutional Moves & Fast Exit Strategy with Risk Control - Newser
Relief Rally in Krystal Biotech Inc. Stock — Can It Hold getLinesFromResByArray error: size == 0 - 강소기업뉴스
Can Krystal Biotech Inc. Rally Enough to Break Even2025 Valuation Update & High Win Rate Trade Alerts - beatles.ru
Sector ETF performance correlation with Krystal Biotech Inc.Market Growth Report & Risk Managed Trade Strategies - Newser
Krystal Biotech Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Price Swings & High Conviction Buy Zone Alerts - beatles.ru
Will Krystal Biotech Inc. rebound enough to break evenRecession Risk & Weekly High Potential Stock Alerts - Newser
Is Krystal Biotech Inc. stock poised for growthMarket Performance Recap & Growth Oriented Trading Recommendations - Newser
MACD Cross Could Confirm Trend in Krystal Biotech Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Krystal Biotech Inc Stock (KRYS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Krystal Biotech Inc Stock (KRYS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Krishnan Suma | President, R&D |
Jul 14 '25 |
Sale |
150.30 |
13,400 |
2,014,015 |
1,512,529 |
| Krishnan Suma | President, R&D |
Jul 15 '25 |
Sale |
151.01 |
3,084 |
465,700 |
1,509,445 |
| Krishnan Suma | President, R&D |
Jul 15 '25 |
Sale |
150.98 |
3,036 |
458,361 |
1,440,240 |
| Krishnan Suma | President, R&D |
Jul 16 '25 |
Sale |
150.00 |
1,529 |
229,350 |
1,438,711 |
| Krishnan Suma | President, R&D |
Jul 16 '25 |
Sale |
150.00 |
1,389 |
208,350 |
1,508,056 |
| Krishnan Krish S | President and CEO |
Jul 14 '25 |
Sale |
150.30 |
13,435 |
2,019,225 |
1,443,276 |
| Krishnan Krish S | President and CEO |
Jul 14 '25 |
Sale |
150.30 |
13,400 |
2,014,015 |
1,512,529 |
| Krishnan Krish S | President and CEO |
Jul 15 '25 |
Sale |
151.01 |
3,084 |
465,700 |
1,509,445 |
| Krishnan Krish S | President and CEO |
Jul 15 '25 |
Sale |
150.98 |
3,036 |
458,361 |
1,440,240 |
| Krishnan Krish S | President and CEO |
Jul 16 '25 |
Sale |
150.00 |
1,529 |
229,350 |
1,438,711 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):